Arcturus Therapeutics: 2Q Earnings Snapshot
SAN DIEGO (AP) _ Arcturus Therapeutics (ARCT) on Thursday reported a loss of $685,000 in its second quarter.
The San Diego-based company said it had a loss of 7 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 53 cents per share.
The pharmaceutical company posted revenue of $10.2 million in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $4 million.
Arcturus Therapeutics shares have more than doubled since the beginning of the year. The stock has climbed 14% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARCT at https://www.zacks.com/ap/ARCT